Ident. | Authors (with country if any) | Title |
---|
000040 (2013) |
Isabelle Boileau [Canada, Niger] ; Doris Payer [Canada] ; Bindiya Chugani [Canada] ; Daniela Lobo [Canada] ; Arian Behzadi [Canada] ; Pablo M. Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jerry Warsh [Canada] ; Stephen J. Kish [Canada] ; Martin Zack [Canada] | The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]‐(+)‐propyl‐hexahydro‐naphtho‐oxazin and [11C]raclopride |
000072 (2013) |
Ji Hyun Ko [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease |
000073 (2013) |
Thilo Van Eimeren [Canada, Allemagne] ; Ji H. Ko [Canada] ; Giovanna Pellechia [Canada] ; Sang S. Cho [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Prefrontal D2‐receptor stimulation mediates flexible adaptation of economic preference hierarchies |
000117 (2013) |
Vincent Degos [France, États-Unis] ; Stéphane Peineau [France, Royaume-Uni] ; Cora Nijboer [Pays-Bas] ; Angela M. Kaindl [France, Allemagne] ; Stéphanie Sigaut [France] ; Géraldine Favrais [France] ; Frank Plaisant [France] ; Natacha Teissier [France] ; Elodie Gouadon [France] ; Alain Lombet [France] ; Elie Saliba [France] ; Graham L. Collingridge [Royaume-Uni, Canada, Corée du Sud] ; Mervyn Maze [États-Unis] ; Ferdinando Nicoletti [Italie] ; Cobi Heijnen [Pays-Bas] ; Jean Mantz [France] ; Annemieke Kavelaars [Pays-Bas] ; Pierre Gressens [France, Royaume-Uni] | G protein–coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation‐induced sensitization to excitotoxic neurodegeneration |
000260 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Tayyeba Darr [Canada] ; Donna Pires [Canada] ; Lili-Naz Hazrati [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Increased levels of 5‐HT1A receptor binding in ventral visual pathways in Parkinson's disease |
000297 (2012) |
Sai Prasad Pydi [Canada] ; Rajinder Pal Bhullar [Canada] ; Prashen Chelikani [Canada] | Constitutively active mutant gives novel insights into the mechanism of bitter taste receptor activation |
000361 (2011) |
James B. Koprich [Canada] ; Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; Allan Goodman [États-Unis] ; Bertrand Le Bourdonnec [États-Unis] ; Roland E. Dolle [États-Unis] ; Robert N. Dehaven [États-Unis] ; Diane L. Dehaven-Hudkins [États-Unis] ; Patrick J. Little [États-Unis] ; Jonathan M. Brotchie [Canada] | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
000439 (2011) |
Nancy Knight [Canada] ; Nancy Hallett [Royaume-Uni] ; Nancy Brancale [Royaume-Uni] ; Nancy Paisey [Royaume-Uni] ; Nancy Clarkson [Royaume-Uni] ; Nancy Edwards [Royaume-Uni] | Evaluation of a Fluorescent Derivative of AMD3100 and its Interaction with the CXCR4 Chemokine Receptor |
000603 (2010) |
Jun Liu [République populaire de Chine, États-Unis] ; Min Shi [États-Unis] ; Zhen Hong [République populaire de Chine] ; Jianpeng Zhang [États-Unis] ; Joshua Bradner [États-Unis] ; Thomas Quinn [États-Unis] ; Richard P. Beyer [États-Unis] ; Patrick L. Mcgeer [Canada] ; Shengdi Chen [République populaire de Chine] ; Jing Zhang [États-Unis] | Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α‐synuclein |
000623 (2010) |
Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada] | Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease |
000779 (2009) |
Philip Seeman [Canada] ; Hong-Chang Guan [Canada] | Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor |
000780 (2009) |
Lucie Canaff [Canada] ; Xiang Zhou [Canada] ; Irina Mosesova [Canada] ; David E. C. Cole [Canada] ; Geoffrey N. Hendy [Canada] | Glial Cells Missing‐2 (GCM2) transactivates the calcium‐sensing receptor gene: effect of a dominant‐negative GCM2 mutant associated with autosomal dominant hypoparathyroidism |
000799 (2009) |
L. Almarestani [Canada] ; S. M. Waters [États-Unis] ; J. E. Krause [États-Unis] ; G. J. Bennett [Canada] ; A. Ribeiro-Da-Silva [Canada] | De novo expression of the neurokinin 1 receptor in spinal lamina I pyramidal neurons in polyarthritis |
000884 (2008) |
Joohyung Lee [Canada, Australie] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi Visanji [Canada] ; Jonathan M. Brotchie [Canada] | Receptor‐activity modifying protein 1 expression is increased in the striatum following repeated L‐DOPA administration in a 6‐hydroxydopamine lesioned rat model of Parkinson's disease |
000899 (2008) |
Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys |
000965 (2008) |
Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis] | Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) |
000A08 (2007) |
Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada] | Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia |
000B42 (2006) |
Maryvonne Le Saux [Canada] ; Erika Estrada-Camarena [Canada] ; Thérèse Di Paolo [Canada] | Selective estrogen receptor‐α but not ‐β agonist treatment modulates brain α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors |
000B48 (2006) |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of levodopa‐induced dyskinesias by a selective NR1A/2B N‐methyl‐D‐aspartate receptor antagonist in parkinsonian monkeys: Implication of preproenkephalin |
000B49 (2006) |
Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors |
000C28 (2006) |
Lara Fallon [Canada] ; Catherine M. L. Blanger [Canada] ; Amadou T. Corera [Canada] ; Maria Kontogiannea [Canada] ; Elsa Regan-Klapisz [Pays-Bas] ; France Moreau [Canada] ; Jarno Voortman [Pays-Bas] ; Michael Haber [Canada] ; Genevive Rouleau [Canada] ; Thorhildur Thorarinsdottir [Canada] ; Alexis Brice [France] ; Paul M. P. Van Bergen En Henegouwen [Pays-Bas] ; Edward A. Fon [Canada] | A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)KAkt signalling |